International Stem Cell (ISCO) Cash from Investing Activities (2010 - 2025)
International Stem Cell (ISCO) posted quarterly Cash from Investing Activities of -$5000.0 for Q4 2025, down 66.67% year-over-year from -$15000.0 in Q4 2024, and down 66.67% quarter-over-quarter from -$3000.0 in Q3 2025.
International Stem Cell (ISCO) Cash from Investing Activities (2010 - 2025) Analysis & Trends
International Stem Cell (ISCO) has reported Cash from Investing Activities for 16 consecutive years, with -$5000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash from Investing Activities fell 66.67% year-over-year to -$5000.0; the TTM figure through Dec 2025 stood at -$45000.0 (up 73.68% YoY), while the FY2025 annual figure was -$45000.0, up 73.68% from the prior year.
- Cash from Investing Activities slipped to -$5000.0 in Q4 2025 per ISCO's latest filing, from -$3000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$2000.0 in Q1 2021 and bottomed at -$119000.0 in Q2 2024.
- Historically, Cash from Investing Activities has averaged -$19500.0 across 5 years, with a median of -$7000.0 in 2024.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities jumped 95.12% — and 2023, when it sank 250.0%.
- International Stem Cell's Cash from Investing Activities stood at -$18000.0 in 2021, then surged by 83.33% to -$3000.0 in 2022, then changed by 0.0% to -$3000.0 in 2023, then changed by 0.0% to -$3000.0 in 2024, then slumped by 66.67% to -$5000.0 in 2025.
- Business Quant data shows ISCO's Cash from Investing Activities at -$5000.0 in Q4 2025, -$3000.0 in Q3 2025, and -$32000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | International Stem Cell | 3.76 Mn | 2.67 Mn | 1.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -32,000.00 |
| Jun 30, 2025 | -32,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | -40,000.00 |
| Sep 30, 2024 | -40,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Jun 30, 2024 | -119,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | -14,000.00 |
| Sep 30, 2023 | -14,000.00 |